Literature DB >> 19289517

Regulation of mprF in daptomycin-nonsusceptible Staphylococcus aureus strains.

Soo-Jin Yang1, Yan Q Xiong, Paul M Dunman, Jacques Schrenzel, Patrice François, Andreas Peschel, Arnold S Bayer.   

Abstract

We used a well-characterized isogenic set of clinical bloodstream Staphylococcus aureus strains to study (i) regulation of mprF-mediated phosphatidylglycerol lysinylation in the contexts of in vitro daptomycin (DAP) nonsuceptibility and (ii) the role of mprF mutation in endovascular virulence. We observed a correlation between increased expression of a mutant mprF gene and reduced in vitro DAP susceptibility. There were no detectable fitness differences between strains in experimental infective endocarditis.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19289517      PMCID： PMC2687189          DOI： 10.1128/AAC.01415-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  17 in total

Review 1.  How do bacteria resist human antimicrobial peptides?

Authors:  Andreas Peschel
Journal:  Trends Microbiol       Date:  2002-04       Impact factor: 17.079

2.  Development of Daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus.

Authors:  M K Hayden; K Rezai; R A Hayes; K Lolans; J P Quinn; R A Weinstein
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

3.  DltABCD- and MprF-mediated cell envelope modifications of Staphylococcus aureus confer resistance to platelet microbicidal proteins and contribute to virulence in a rabbit endocarditis model.

Authors:  Christopher Weidenmaier; Andreas Peschel; Volkhard A J Kempf; Natalie Lucindo; Michael R Yeaman; Arnold S Bayer
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

4.  Lack of wall teichoic acids in Staphylococcus aureus leads to reduced interactions with endothelial cells and to attenuated virulence in a rabbit model of endocarditis.

Authors:  Christopher Weidenmaier; Andreas Peschel; Yan-Qiong Xiong; Sascha A Kristian; Klaus Dietz; Michael R Yeaman; Arnold S Bayer
Journal:  J Infect Dis       Date:  2005-04-11       Impact factor: 5.226

5.  Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin.

Authors:  Daniel J Skiest
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

6.  A LysR-type regulator, CidR, is required for induction of the Staphylococcus aureus cidABC operon.

Authors:  Soo-Jin Yang; Kelly C Rice; Raquel J Brown; Toni G Patton; Linda E Liou; Yong Ho Park; Kenneth W Bayles
Journal:  J Bacteriol       Date:  2005-09       Impact factor: 3.490

7.  Evaluation of endocarditis caused by methicillin-susceptible Staphylococcus aureus developing nonsusceptibility to daptomycin.

Authors:  George Sakoulas; Warren Rose; Michael J Rybak; Satish Pillai; Jeff Alder; Robert C Moellering; George M Eliopoulos
Journal:  J Clin Microbiol       Date:  2007-11-14       Impact factor: 5.948

8.  Activation and transcriptional interaction between agr RNAII and RNAIII in Staphylococcus aureus in vitro and in an experimental endocarditis model.

Authors:  Yan-Qiong Xiong; William Van Wamel; Cynthia C Nast; Michael R Yeaman; Ambrose L Cheung; Arnold S Bayer
Journal:  J Infect Dis       Date:  2002-08-09       Impact factor: 5.226

9.  Comparative efficacies of liposomal amikacin (MiKasome) plus oxacillin versus conventional amikacin plus oxacillin in experimental endocarditis induced by Staphylococcus aureus: microbiological and echocardiographic analyses.

Authors:  Y Q Xiong; L I Kupferwasser; P M Zack; A S Bayer
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

10.  Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine.

Authors:  A Peschel; R W Jack; M Otto; L V Collins; P Staubitz; G Nicholson; H Kalbacher; W F Nieuwenhuizen; G Jung; A Tarkowski; K P van Kessel; J A van Strijp
Journal:  J Exp Med       Date:  2001-05-07       Impact factor: 14.307
View more
  61 in total

1.  Daptomycin-mediated reorganization of membrane architecture causes mislocalization of essential cell division proteins.

Authors:  Joe Pogliano; Nicolas Pogliano; Jared A Silverman
Journal:  J Bacteriol       Date:  2012-06-01       Impact factor: 3.490

2.  Novel daptomycin combinations against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro model of simulated endocardial vegetations.

Authors:  Molly E Steed; Celine Vidaillac; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2010-10-04       Impact factor: 5.191

Review 3.  Roles of tRNA in cell wall biosynthesis.

Authors:  Kiley Dare; Michael Ibba
Journal:  Wiley Interdiscip Rev RNA       Date:  2012-01-19       Impact factor: 9.957

Review 4.  Mechanisms of drug resistance: daptomycin resistance.

Authors:  Truc T Tran; Jose M Munita; Cesar A Arias
Journal:  Ann N Y Acad Sci       Date:  2015-10-23       Impact factor: 5.691

5.  In vitro cross-resistance to daptomycin and host defense cationic antimicrobial peptides in clinical methicillin-resistant Staphylococcus aureus isolates.

Authors:  Nagendra N Mishra; James McKinnell; Michael R Yeaman; Aileen Rubio; Cynthia C Nast; Liang Chen; Barry N Kreiswirth; Arnold S Bayer
Journal:  Antimicrob Agents Chemother       Date:  2011-06-27       Impact factor: 5.191

Review 6.  Bacterial resistance mechanisms against host defense peptides.

Authors:  Tomaz Koprivnjak; Andreas Peschel
Journal:  Cell Mol Life Sci       Date:  2011-05-11       Impact factor: 9.261

Review 7.  A current perspective on daptomycin for the clinical microbiologist.

Authors:  Romney M Humphries; Simon Pollett; George Sakoulas
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

8.  Correlation of cell membrane lipid profiles with daptomycin resistance in methicillin-resistant Staphylococcus aureus.

Authors:  Nagendra N Mishra; Arnold S Bayer
Journal:  Antimicrob Agents Chemother       Date:  2012-12-17       Impact factor: 5.191

9.  Evaluation of the novel combination of high-dose daptomycin plus trimethoprim-sulfamethoxazole against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus using an in vitro pharmacokinetic/pharmacodynamic model of simulated endocardial vegetations.

Authors:  Molly E Steed; Brian J Werth; Cortney E Ireland; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

10.  Activity of telavancin against staphylococci and enterococci determined by MIC and resistance selection studies.

Authors:  Klaudia Kosowska-Shick; Catherine Clark; Glenn A Pankuch; Pamela McGhee; Bonifacio Dewasse; Linda Beachel; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2009-07-20       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.